New Insulet CEO Ashley McEvoy sets priorities

New Insulet CEO Ashley McEvoy sets priorities

The diabetes tech company raised its expectations for revenue and gross margins, despite the impact of tariffs.

Insulet Posts Upbeat Earnings, Joins Trade Desk, TransMedics Group, Tesla And Other Big Stocks Moving Higher On Friday - Definitive Healthcare (NASDAQ:DH), AvePoint (NASDAQ:AVPT)

Insulet Posts Upbeat Earnings, Joins Trade Desk, TransMedics Group, Tesla And Other Big Stocks Moving Higher On Friday

U.S. stocks were higher, with the Nasdaq Composite gaining around 100 points on Friday. Shares of Insulet Corporation (NASDAQ:PODD) rose sharply during Friday's session after the company reported better-than-expected first-quarter financial results and raised its FY25 sales guidance above…

Insulet stock rises on Street-beating Q1, 29% sales uptick

Insulet (Nasdaq:PODD) shares got a boost after hours today on first-quarter results that came in ahead of the consensus forecast. Shares of PODD rose 7% to $275.02 apiece in post-market trading today. The Acton, Massachusetts-based automated insulin delivery technology maker reported profits of $35.4 million. That equals 50¢ per share on sales of $569 million for the three months ended March 31, 2025. Insulet recorded a 31.3% bottom-line slide o…